Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction

Franco De Conno, Augusto Caraceni, Ernesto Zecca, Elio Spoldi, Vittorio Ventafridda

Research output: Contribution to journalArticle

Abstract

We describe the use of hyoscine butylbromide as a subcutaneous infusion in 3 patients with inoperable malignant bowel obstruction. An objective reduction of drainage from the gastrointestinal tract was observed with the hyoscine butylbromide infusion (60-120 mg/day). We suggest that this effect can be useful in the palliative treatment of vomiting in inoperable bowel obstruction.

Original languageEnglish
Pages (from-to)484-486
Number of pages3
JournalJournal of Pain and Symptom Management
Volume6
Issue number8
DOIs
Publication statusPublished - 1991

Keywords

  • GI secretions
  • Hyoscine butylbromide
  • malignant GI obstruction

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Fingerprint Dive into the research topics of 'Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction'. Together they form a unique fingerprint.

  • Cite this